Lexeo Therapeutics (LXEO) Gains from Investment Securities (2022 - 2026)
Lexeo Therapeutics' (LXEO) quarterly Gains from Investment Securities came in at $52285.0 in Q1 2026, down 67.12% year-on-year from $159000.0 in Q1 2025, and down 69.06% quarter-over-quarter from $169000.0 in Q4 2025.
Lexeo Therapeutics (LXEO) Gains from Investment Securities (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has disclosed Gains from Investment Securities across 5 years of filings, most recently posting $52285.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $52285.0, down 67.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $52285.0 (down 88.63% YoY), and the FY2025 annual result was $4.4 million, up 27.15% from the prior year.
- Gains from Investment Securities came in at $52285.0 for Q1 2026 at Lexeo Therapeutics, down from $169000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $581954.0 in Q3 2023 to a low of $36000.0 in Q3 2022.
- The 5-year median for Gains from Investment Securities is $108000.0 (2022), against an average of $134494.5.
- Across the five-year window, Gains from Investment Securities jumped 1516.54% in 2023 and tumbled 80.93% in 2024, its largest moves.
- Lexeo Therapeutics' Gains from Investment Securities stood at $108000.0 in 2022, then decreased by 2.78% to $105000.0 in 2023, then increased by 10.48% to $116000.0 in 2024, then soared by 45.69% to $169000.0 in 2025, then slumped by 69.06% to $52285.0 in 2026.
- The last three Gains from Investment Securities figures came in at $52285.0 (Q1 2026), $169000.0 (Q4 2025), and $83000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Lexeo Therapeutics | 358.83 Mn | 165.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52,285.00 |
| Mar 31, 2026 | 52,285.00 |
| Dec 31, 2025 | 169,000.00 |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 83,000.00 |
| Sep 30, 2025 | 83,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Mar 31, 2025 | 159,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Sep 30, 2024 | 111,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 87,179.00 |
| Mar 31, 2024 | 87,179.00 |
| Dec 31, 2023 | 105,000.00 |
| Dec 31, 2023 | 105,000.00 |